Back to ENTA
Krensavage Asset Management, LLC → ENTA
Krensavage Asset Management, LLC ENTA Position History
Enanta Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$37.8M
Q3 2026
Peak value
$43.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $43.6M |
| Q1 2026 | $36.2M |
| Q2 2026 | $41.8M |
| Q3 2026 | $37.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $37.8M | 2.87M | — | — |
| Q2 2026 | $41.8M | 2.87M | — | — |
| Q1 2026 | $36.2M | 2.87M | — | — |
| Q4 2025 | $43.6M | 2.77M | — | — |